Integrated platform-based innovative biopharma for inhalation formulations

**Our Mission** Rooted in an integrated China-global innovation ecosystem, we build on high-value complex formulations, pioneer breakthrough innovative drugs, and are driven by proprietary delivery technologies to address the world’s most urgent unmet clinical needs. **Device engineering, precision drug delivery, global regulatory filing and commercialization** As a global innovator in inhalation drug delivery technology, CF is dedicated to building multidisciplinary bridges between complex formulations and unmet clinical needs. **Fully self-developed, globally integrated end-to-end capabilities** From breath-powered nasal spray delivery systems and liposomal inhalation technology to siRNA nucleic acid delivery platforms, the Company is systematically advancing its innovation pipeline targeting the Chinese, U.S. and European markets. **In-depth Layout in Therapeutic Areas** We maintain an in-depth layout in respiratory diseases (asthma, COPD and bronchiectasis) and rhinological diseases (allergic rhinitis and chronic sinusitis). We also strategically expand into pulmonary fibrosis, pulmonary arterial hypertension, rare pulmonary infections and central nervous system diseases, taking the lead in exploring the cutting-edge frontier of precise drug delivery via the nose-to-brain pathway. CF has established an extensively covered three-dimensional commercial network in China. With a globally compliant manufacturing system and deepening overseas layout, it is steadily advancing towards the development goal of becoming a global innovative pharmaceutical enterprise.